Syndax Pharmaceuticals shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Syndax Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Syndax Pharmaceuticals held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Syndax Pharmaceuticals by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.8M | 574k | 15.39 |
| 2025-06-30 | $5.4M | 574k | 9.37 |
| 2025-03-31 | $5.3M | 433k | 12.29 |
| 2024-12-31 | $3.1M | 232k | 13.22 |
| 2024-09-30 | $5.0M | 260k | 19.25 |
| 2024-06-30 | $4.7M | 229k | 20.53 |
| 2024-03-31 | $4.2M | 179k | 23.80 |
More positions owned by Rhenman & Partners Asset Management AB
View all positions for Rhenman & Partners Asset Management AB